Two prominent companies with a strong foothold in this space are Hologic HOLX and Myriad Genetics MYGN. Hologic’s molecular diagnostics offerings specialize in women’s health and acute ...

Hologic (HOLX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Hologic, Inc. (Nasdaq: HOLX) will have a strong presence at the Society of Breast Imaging (SBI) Annual Symposium in Colorado Springs, Colorado this week, including the presentation of pivotal new ...

Hologic, Inc. (NASDAQ:HOLX – Get Free Report) has earned a consensus recommendation of “Hold” from the seventeen analysts that are currently covering the company, Marketbeat.com reports.

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a company that develops industry-leading technologies that detect, diagnose and treat life-changing health conditions that affect ...

Report highlights efforts to enhance access and equity in women's health and invest in the future with science-based environmental targets, employee development and community engagement Hologic ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) will have a strong presence at the Society of Breast Imaging (SBI) Annual Symposium in Colorado Springs, Colorado this week ...

As you can see from the chart above the percentage of shares that are sold short for Hologic has grown since its last report. This does not mean that the stock is going to fall in the near-term ...

Hologic HOLX is set to release second-quarter fiscal 2025 results on May 1, after the closing bell. The Zacks Consensus Estimate for second-quarter earnings suggests a 0.97% decrease year over ...